In our study we have shown that the ability of colon cancer cells to compensate glutamine withdrawal by asparagine supplementation did solely depend on intracellular de novo glutamine synthesis by glutamine synthetase (GLUL). The gene discussed is GLUL; the disease is malignant colon neoplasm.